


<!DOCTYPE html>
<html lang="en">
<head><script src="//archive.org/includes/analytics.js?v=cf34f82" type="text/javascript"></script>
<script type="text/javascript">window.addEventListener('DOMContentLoaded',function(){var v=archive_analytics.values;v.service='wb';v.server_name='wwwb-app19.us.archive.org';v.server_ms=903;archive_analytics.send_pageview({});});</script><script type="text/javascript" src="/static/js/wbhack.js?v=1531166943.0" charset="utf-8"></script>

<script type="text/javascript">
__wbhack.init('https://web.archive.org/web');
</script>
<link rel="stylesheet" type="text/css" href="/static/css/banner-styles.css?v=1531166943.0" />
<link rel="stylesheet" type="text/css" href="/static/css/iconochive.css?v=1531166943.0" />

<!-- End Wayback Rewrite JS Include -->  

        <title>Guidelines for the minimally invasive treatment of adrenal pathology. | National Guideline Clearinghouse</title>

    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width">
    <link rel="icon" href="/web/20180712203526im_/https://www.guideline.gov/UI/images/favicon-NGC.ico">
    <link rel="apple-touch-icon" sizes="180x180" href="/web/20180712203526im_/https://www.guideline.gov/UI/images/apple-touch-icon-NGC.png">
    <link rel="icon" type="image/png" href="/web/20180712203526im_/https://www.guideline.gov/UI/images/favicon-NGC-32x32.png" sizes="32x32">
    <link rel="icon" type="image/png" href="/web/20180712203526im_/https://www.guideline.gov/UI/images/favicon-NGC-16x16.png" sizes="16x16">
    <link rel="manifest" href="/web/20180712203526/https://www.guideline.gov/UI/images/manifest-NGC.json">
    <link rel="mask-icon" href="/web/20180712203526im_/https://www.guideline.gov/UI/images/safari-pinned-tab-NGC.svg" color="#1d4345">
    <meta name="theme-color" content="#ffffff">
    
<link href="/web/20180712203526cs_/https://www.guideline.gov/cassette.axd/stylesheet/8382974d7bae1577062376dcd37102348398fe04/NGCSiteCSS" type="text/css" rel="stylesheet"/>
<!--[if lt IE 9]>
<link href="/cassette.axd/stylesheet/2188ac5b8507764bb4079068f7a3c8d7ccfba0e7/ieCSS" type="text/css" rel="stylesheet"/>
<![endif]-->



    <script async type="text/javascript" id="_fed_an_ua_tag" src="https://web.archive.org/web/20180712203526js_/https://dap.digitalgov.gov/Universal­-Federated-­Analytics-­Min.js?agency=HHS&amp;subagency=AHRQ"></script>
    </head>
<body class="no-js content-page">
<a href="#main-content" id="skip-nav">Skip to main content</a>
<!--https://developers.google.com/tag-manager/devguide#multidomain  ECH-1199-->
    
    <!-- Google Tag Manager -->
    <noscript>
        <iframe src="//web.archive.org/web/20180712203526if_/https://www.googletagmanager.com/ns.html?id=GTM-W4NX5V" height="0" width="0" style="display:none;visibility:hidden"></iframe>
    </noscript>
    <script>
        (function (w, d, s, l, i) {
            w[l] = w[l] || []; w[l].push({
                'gtm.start':
                new Date().getTime(), event: 'gtm.js'
            }); var f = d.getElementsByTagName(s)[0],
            j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src =
            '//web.archive.org/web/20180712203526/https://www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f);
        })(window, document, 'script', 'dataLayer', 'GTM-W4NX5V');</script>

    <noscript>
        <iframe src="//web.archive.org/web/20180712203526if_/https://www.googletagmanager.com/ns.html?id=GTM-KHDP6Z" height="0" width="0" style="display:none;visibility:hidden"></iframe>
    </noscript>
    <script>
        (function (w, d, s, l, i) {
            w[l] = w[l] || []; w[l].push({
                'gtm.start':
                new Date().getTime(), event: 'gtm.js'
            }); var f = d.getElementsByTagName(s)[0],
            j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src =
            '//web.archive.org/web/20180712203526/https://www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f);
        })(window, document, 'script', 'dataLayer', 'GTM-KHDP6Z');</script>
    <!-- End Google Tag Manager -->


    <!-- AHRQ HEADER -->
<div id="ahrq-header">

	<p class="hhs-links">
		<a href="https://web.archive.org/web/20180712203526/http://www.hhs.gov/" target="_blank" class="logo-hhs"><span class="logomark"></span>U.S.&nbsp;Department of&nbsp;Health&nbsp;and Human&nbsp;Services</a>
		<a href="https://web.archive.org/web/20180712203526/http://www.hhs.gov/" target="_blank" class="external-link"><strong>HHS.gov</strong></a>
	</p><!-- /.hhs-links -->
	<p class="ahrq-links">
		<a href="https://web.archive.org/web/20180712203526/http://www.ahrq.gov/" target="_blank" class="logo-ahrq">Agency for Healthcare Research and Quality: Advancing Excellence in Health Care</a>
		<a href="https://web.archive.org/web/20180712203526/http://www.ahrq.gov/" target="_blank" class="external-link"><strong>AHRQ.gov</strong></a>
	</p><!-- /.ahrq-links -->

</div><!-- /#ahrq-header -->

	<!-- HEADER -->
	<div class="header" id="header">
		<div class="masthead">

			<ul class="header-actions">
				<li><a href="#header-search" class="search-action"><span class="label">Search</span></a></li>
				<li><a href="#header-account" class="account-action"><span class="label">Account</span></a></li>
				<li><a href="#main-nav" class="menu-action"><span class="label">Menu</span></a></li>
			</ul><!-- /.header-actions -->
				
				<a href="/web/20180712203526/https://www.guideline.gov/" class="header-logo NGC">
				    <picture>
				        <source media="(min-width: 960px)" srcset="/web/20180712203526im_/https://www.guideline.gov/UI/images/logo_NGC_header.png">
				        <source srcset="/web/20180712203526im_/https://www.guideline.gov/UI/images/logo_NGC_header_m.png">
				        <img src="/web/20180712203526im_/https://www.guideline.gov/UI/images/logo_NGC_header.png" alt="National Guideline Clearinghouse">
				    </picture>
				</a>
<form action="/web/20180712203526/https://www.guideline.gov/search" class="header-search header-action" enctype="multipart/form-data" id="header-search" method="get">					<p class="search-bar">
						<label for="q"><span class="screen-reader-text">Search</span>
							<input id="q" type="text" title="Search Input" name="q" class="search-input" placeholder="Search">
						</label>
						<input id="masthead-search-button" type="submit" title="Search Submit" class="search-submit" value="Search">
					</p>
					<p class="search-tips">
						<a href="/web/20180712203526/https://www.guideline.gov/help-and-about/search-browse/search-tips">Search Tips</a>
					</p>
</form>				<div class="header-account header-action" id="header-account">
				<a id="login-button" class="signin" href="/web/20180712203526/https://www.guideline.gov/accounts/signinlanding" aria-role="tab" aria-controls="login-panel" aria-selected="false">Log into My NGC</a>
<div id="login-panel" class="login dropdown" aria-role="tab-panel" aria-labeledby="login-button" aria-hidden="true">
    
            <div class="sign-in">
            <form id="sign-in-form" action="/web/20180712203526/https://www.guideline.gov/Accounts/LoginSubmit" method="post">
                <h3>Sign In</h3>
                <div class="errormessages"></div>
                <p class="invalid-user-cred message-block" style="display: none;"></p>
                <p>
                    <label for="sign-in-username">Username or Email <span class="required">*</span></label>
                    <input type="text" id="sign-in-username" class="input-text" name="email" required>
                   
                </p>
                <p>
                    <label for="sign-in-userpwd">Password <span class="required">*</span></label>
                    <input type="password" id="sign-in-userpwd" class="input-text" name="password" required>
                  
                </p>
                <p class="form-link"><a href="/web/20180712203526/https://www.guideline.gov/accounts/forgotpassword">Forgot Password?</a></p>
                <p><label for="remember-me"><input type="checkbox" name="remember-me" id="remember-me">Remember Me</label></p>
                <input id="account-sign-in" type="submit" value="Sign In"/>
            </form>
            <p>
                <label for="sign-up-btn">Don't have an account?</label>
                <a href="/web/20180712203526/https://www.guideline.gov/accounts/login" class="sign-up-btn" id="sign-up-btn">Create New Account</a>
            </p>
        </div><!--/.sign-in-->
</div><!-- /.login -->
				</div><!-- /.header-account -->
		</div><!-- /.masthead -->

		<div class="main-nav header-action" id="main-nav">
		    <ul class="level-1">
		        <li class=""><a href="/web/20180712203526/https://www.guideline.gov/">Home</a></li>
		        <li class=""><a href="/web/20180712203526/https://www.guideline.gov/new-this-week/index">New This Week</a></li>
		        <li>
<a href="/web/20180712203526/https://www.guideline.gov/summaries/browse" class="parent-link">Guideline Summaries</a>                    		            <ul class="level-2 dropdown">
                             <li class=""><a href="/web/20180712203526/https://www.guideline.gov/browse/clinical-specialty">By Clinical Specialty</a></li>
		                <li class=""><a href="/web/20180712203526/https://www.guideline.gov/browse/organization">By Organization</a></li>
		                <li class=""><a href="/web/20180712203526/https://www.guideline.gov/browse/mesh-tag">By MeSH Tag</a></li>
		                <li class=""><a href="/web/20180712203526/https://www.guideline.gov/summaries/in-progress">In Progress</a></li>
		                <li class=""><a href="/web/20180712203526/https://www.guideline.gov/summaries/archive">Archive</a></li>

		                <li class=""><a href="/web/20180712203526/https://www.guideline.gov/search?f_DocType=0&amp;fLockTerm=Guideline Summaries">All Summaries</a></li>
		            </ul>
		        </li>
<li class=""><a href="/web/20180712203526/https://www.guideline.gov/syntheses/index">Guideline Syntheses</a></li>		        <li class=""><a href="/web/20180712203526/https://www.guideline.gov/expert">Expert Commentaries</a></li>
		        <li class=""><a href="/web/20180712203526/https://www.guideline.gov/matrix">Matrix Tool</a></li>
		        <li class="">
<a href="/web/20180712203526/https://www.guideline.gov/summaries/submit">Submit Guidelines</a>                    		        </li>
                <li class=""><a href="/web/20180712203526/https://www.guideline.gov/help-and-about">Help &amp;&nbsp;About</a></li>		      
		    </ul>
		</div><!-- /.main-nav -->
</div><!-- /.header -->

    <br/><div class="content"><div class="fundingNotice2"><b>The AHRQ National Guideline Clearinghouse (NGC, guideline.gov) Web site will not be available after July 16, 2018</b> because federal funding <br/>through AHRQ will no longer be available to support the NGC as of that date. For additional information, read our <a href="/web/20180712203526/https://www.guideline.gov/home/announcements">full announcement</a>.</div></div>

	<!-- CONTENT -->
	<main id="main-content" tabindex="-1">
		

<div class="main">

		<div class="aside-container">

	<div class="content">

    <!-- CONTENT HEADER -->
    <div class="content-header">
        <ul class="content-header-meta">
            <li class="prefix-icon guideline">Guideline Summary</li>
            <li>NGC:009739</li>
            <li>2013 Feb
            </li>            
                                </ul>
        <div>
                <h1>Guidelines for the minimally invasive treatment of adrenal pathology.</h1>
        </div>
    </div>
    <!-- /.content-header-meta -->

        <!-- CONTENT TABS -->
        <ul class="content-tabs">
            <li><a href="#developer-tab" class="developer is-active"><span class="label">Developer</span></a></li>
            <li><a href="#source-tab" class="source"><span class="label">Source</span></a></li>
            <li><a href="#status-tab" class="status"><span class="label">Status</span></a></li>
            <li><a href="#classification-tab" class="classification"><span class="label">Classification</span></a></li>
        </ul>
        <div id="developer-tab" class="is-active content-tab-panel">
                <ul class="developer-list">
        <li><a href="/web/20180712203526/https://www.guideline.gov/search?f_Guideline_Developer_String=Society%20of%20American%20Gastrointestinal%20and%20Endoscopic%20Surgeons&amp;fLockTerm=Society%2Bof%2BAmerican%2BGastrointestinal%2Band%2BEndoscopic%2BSurgeons">Society of American Gastrointestinal and Endoscopic Surgeons</a></li>
                        <li>   
                                <a id="124" href="#" data-alert="SignInLanding" data-alert-type="organization" class="get-alerts get-org-alerts">Get Alerts</a>
                        </li>
                </ul>
        </div>
    <!-- /.content-tab-panel -->
    <div id="source-tab" class="content-tab-panel">
<table><tr><td>Society of American Gastrointestinal Endoscopic Surgeons (SAGES). Guidelines for the minimally invasive treatment of adrenal pathology. Los Angeles (CA): Society of American Gastrointestinal Endoscopic Surgeons (SAGES); 2013 Feb. 27 p.  [164 references]</td></tr></table>                    <p><a href="/web/20180712203526/https://www.guideline.gov/Home/Disclaimer?id=43951&amp;contentType=fulltextlink&amp;redirect=http%253a%252f%252fwww.sages.org%252fpublications%252fguidelines%252fguidelines-for-the-minimally-invasive-treatment-of-adrenal-pathology%252f">View the original guideline documentation</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712203526im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/></p>
    </div>
    <!-- /.content-tab-panel -->
    <div id="status-tab" class="content-tab-panel">
            <p><div class="content_para"><p>This is the current release of the guideline.</p></div></p>
    </div>
    <!-- /.content-tab-panel -->
    <div id="classification-tab" class="content-tab-panel">


        
                            <h4>UMLS Concepts <a href="/web/20180712203526/https://www.guideline.gov/help-and-about/search-browse/umls-concepts" class="what-is">(what is this?)</a></h4>
                <div class="field">
                    <h5 class="field-label">ICD9CM</h5>
                    <div class="field-content">
<a href="/web/20180712203526/https://www.guideline.gov/search?f_ICD9CM_CUI=C0031150&amp;fLockTerm=Laparoscopy">Laparoscopy</a>
 (54.21), <a href="/web/20180712203526/https://www.guideline.gov/search?f_ICD9CM_CUI=C0750887&amp;fLockTerm=Malignant+neoplasm+of+adrenal+gland">Malignant neoplasm of adrenal gland</a>
 (194.0), <a href="/web/20180712203526/https://www.guideline.gov/search?f_ICD9CM_CUI=C0001621&amp;fLockTerm=Unspecified+disorder+of+adrenal+glands">Unspecified disorder of adrenal glands</a>
 (255.9)                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">MSH</h5>
                    <div class="field-content">
<a href="/web/20180712203526/https://www.guideline.gov/search?f_MSH_CUI=C0001614&amp;fLockTerm=Adrenal+Cortex+Diseases">Adrenal Cortex Diseases</a>
, <a href="/web/20180712203526/https://www.guideline.gov/search?f_MSH_CUI=C0001618&amp;fLockTerm=Adrenal+Cortex+Neoplasms">Adrenal Cortex Neoplasms</a>
, <a href="/web/20180712203526/https://www.guideline.gov/search?f_MSH_CUI=C0001621&amp;fLockTerm=Adrenal+Gland+Diseases">Adrenal Gland Diseases</a>
, <a href="/web/20180712203526/https://www.guideline.gov/search?f_MSH_CUI=C0001624&amp;fLockTerm=Adrenal+Gland+Neoplasms">Adrenal Gland Neoplasms</a>
, <a href="/web/20180712203526/https://www.guideline.gov/search?f_MSH_CUI=C0001632&amp;fLockTerm=Adrenalectomy">Adrenalectomy</a>
, <a href="/web/20180712203526/https://www.guideline.gov/search?f_MSH_CUI=C0206686&amp;fLockTerm=Adrenocortical+Carcinoma">Adrenocortical Carcinoma</a>
, <a href="/web/20180712203526/https://www.guideline.gov/search?f_MSH_CUI=C0023036&amp;fLockTerm=Laparoscopes">Laparoscopes</a>
, <a href="/web/20180712203526/https://www.guideline.gov/search?f_MSH_CUI=C0031150&amp;fLockTerm=Laparoscopy">Laparoscopy</a>
, <a href="/web/20180712203526/https://www.guideline.gov/search?f_MSH_CUI=C0031511&amp;fLockTerm=Pheochromocytoma">Pheochromocytoma</a>
, <a href="/web/20180712203526/https://www.guideline.gov/search?f_MSH_CUI=C0035785&amp;fLockTerm=Robotics">Robotics</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">MTH</h5>
                    <div class="field-content">
<a href="/web/20180712203526/https://www.guideline.gov/search?f_MTH_CUI=C0750887&amp;fLockTerm=Adrenal+Cancer">Adrenal Cancer</a>
, <a href="/web/20180712203526/https://www.guideline.gov/search?f_MTH_CUI=C0001614&amp;fLockTerm=Adrenal+Cortex+Diseases">Adrenal Cortex Diseases</a>
, <a href="/web/20180712203526/https://www.guideline.gov/search?f_MTH_CUI=C0001624&amp;fLockTerm=Adrenal+Gland+Neoplasms">Adrenal Gland Neoplasms</a>
, <a href="/web/20180712203526/https://www.guideline.gov/search?f_MTH_CUI=C0206686&amp;fLockTerm=Adrenocortical+carcinoma">Adrenocortical carcinoma</a>
, <a href="/web/20180712203526/https://www.guideline.gov/search?f_MTH_CUI=C0521267&amp;fLockTerm=Laparoscopic+adrenalectomy+(procedure)">Laparoscopic adrenalectomy (procedure)</a>
, <a href="/web/20180712203526/https://www.guideline.gov/search?f_MTH_CUI=C0031150&amp;fLockTerm=Laparoscopy">Laparoscopy</a>
, <a href="/web/20180712203526/https://www.guideline.gov/search?f_MTH_CUI=C0031511&amp;fLockTerm=Pheochromocytoma">Pheochromocytoma</a>
, <a href="/web/20180712203526/https://www.guideline.gov/search?f_MTH_CUI=C0879117&amp;fLockTerm=Robotic+Surgical+Systems">Robotic Surgical Systems</a>
, <a href="/web/20180712203526/https://www.guideline.gov/search?f_MTH_CUI=C0001618&amp;fLockTerm=Tumors+of+Adrenal+Cortex">Tumors of Adrenal Cortex</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">PDQ</h5>
                    <div class="field-content">
<a href="/web/20180712203526/https://www.guideline.gov/search?f_PDQ_CUI=C0001632&amp;fLockTerm=adrenalectomy">adrenalectomy</a>
, <a href="/web/20180712203526/https://www.guideline.gov/search?f_PDQ_CUI=C0031150&amp;fLockTerm=laparoscopy">laparoscopy</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">SNOMEDCT_US</h5>
                    <div class="field-content">
<a href="/web/20180712203526/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0206686&amp;fLockTerm=Adrenal+carcinoma">Adrenal carcinoma</a>
 (2227007), <a href="/web/20180712203526/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0206686&amp;fLockTerm=Adrenal+carcinoma">Adrenal carcinoma</a>
 (255035007), <a href="/web/20180712203526/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0001632&amp;fLockTerm=Adrenalectomy">Adrenalectomy</a>
 (31904001), <a href="/web/20180712203526/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0001614&amp;fLockTerm=Disorder+of+adrenal+cortex">Disorder of adrenal cortex</a>
 (129636003), <a href="/web/20180712203526/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0001621&amp;fLockTerm=Disorder+of+adrenal+gland">Disorder of adrenal gland</a>
 (30171000), <a href="/web/20180712203526/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0023036&amp;fLockTerm=Laparoscope">Laparoscope</a>
 (86174004), <a href="/web/20180712203526/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0521267&amp;fLockTerm=Laparoscopic+adrenalectomy">Laparoscopic adrenalectomy</a>
 (42843004), <a href="/web/20180712203526/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0031150&amp;fLockTerm=Laparoscopy">Laparoscopy</a>
 (108191006), <a href="/web/20180712203526/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0031150&amp;fLockTerm=Laparoscopy">Laparoscopy</a>
 (73632009), <a href="/web/20180712203526/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0750887&amp;fLockTerm=Malignant+tumor+of+adrenal+gland">Malignant tumor of adrenal gland</a>
 (363355002), <a href="/web/20180712203526/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0001618&amp;fLockTerm=Neoplasm+of+adrenal+cortex">Neoplasm of adrenal cortex</a>
 (127022002), <a href="/web/20180712203526/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0001624&amp;fLockTerm=Neoplasm+of+adrenal+gland">Neoplasm of adrenal gland</a>
 (127021009), <a href="/web/20180712203526/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0161856&amp;fLockTerm=Partial+adrenalectomy">Partial adrenalectomy</a>
 (33756006), <a href="/web/20180712203526/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0031511&amp;fLockTerm=Pheochromocytoma">Pheochromocytoma</a>
 (302835009), <a href="/web/20180712203526/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0031511&amp;fLockTerm=Pheochromocytoma">Pheochromocytoma</a>
 (399343007), <a href="/web/20180712203526/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0031511&amp;fLockTerm=Pheochromocytoma">Pheochromocytoma</a>
 (85583005), <a href="/web/20180712203526/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0879117&amp;fLockTerm=Robotic+surgical+system">Robotic surgical system</a>
 (466893009)                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">SPN</h5>
                    <div class="field-content">
<a href="/web/20180712203526/https://www.guideline.gov/search?f_SPN_CUI=C0023036&amp;fLockTerm=PERITONEOSCOPE">PERITONEOSCOPE</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">UMD</h5>
                    <div class="field-content">
<a href="/web/20180712203526/https://www.guideline.gov/search?f_UMD_CUI=C0023036&amp;fLockTerm=Laparoscopes">Laparoscopes</a>
 (12-291)                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
    </div>
        <!-- /.content-tab-panel -->
        <!-- /.content-tab-panel -->
        <!-- TOOLBAR -->
        <div class="content-toolbar">

            <!-- Primary -->
            <ul class="tools primary-tools">
                <li class="dropdown tool sections">
                    <a href="#" class="tool-button">Sections</a>
                    <div class="dropdown-panel">
                            <ul class="section-links">
                                    <li><a href="#420" class="section-mark">Recommendations</a></li>
                                    <li><a href="#396" class="section-mark">Scope</a></li>
                                    <li><a href="#405" class="section-mark">Methodology</a></li>
                                    <li><a href="#424" class="section-mark">Evidence Supporting the Recommendations</a></li>
                                    <li><a href="#427" class="section-mark">Benefits/Harms of Implementing the Guideline Recommendations</a></li>
                                    <li><a href="#432" class="section-mark">Qualifying Statements</a></li>
                                    <li><a href="#434" class="section-mark">Implementation of the Guideline</a></li>
                                    <li><a href="#439" class="section-mark">Institute of Medicine (IOM) National Healthcare Quality Report Categories</a></li>
                                    <li><a href="#442" class="section-mark">Identifying Information and Availability</a></li>
                                    <li><a href="#99999" class="section-mark">Disclaimer</a></li>
                            </ul>    
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
            </ul>

            <!-- Other -->
            <ul class="tools other-tools">
                <li class="dropdown tool">
                    <a href="#" class="tool-button">Download</a>

                    <div class="dropdown-panel">
                        <ul>
                            <li><a href="/web/20180712203526/https://www.guideline.gov/summaries/downloadcontent/ngc-9739?contentType=pdf" class="pdf">.PDF 91.4 kb</a></li>
                            <li><a href="/web/20180712203526/https://www.guideline.gov/summaries/downloadcontent/ngc-9739?contentType=word" class="word">Word Document 287.6 kb</a></li>
                            <li><a href="/web/20180712203526/https://www.guideline.gov/summaries/downloadcontent/ngc-9739?contentType=xml" class="xml">.XML 38.2 kb</a></li>
                        </ul>
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
                <li class="dropdown tool">
                    <a href="#" class="tool-button">Share</a>
                    <div class="dropdown-panel">
                        <ul class="toolbar-social">
                            <li><a target="_blank" href="https://web.archive.org/web/20180712203526/https://www.facebook.com/sharer/sharer.php?u=https://www.guideline.gov/summaries/summary/43951/guidelines-for-the-minimally-invasive-treatment-of-adrenal-pathology" class="facebook">Facebook</a></li>
                            <li><a target="_blank" href="https://web.archive.org/web/20180712203526/https://twitter.com/share?text=&amp;url=https://www.guideline.gov/summaries/summary/43951/guidelines-for-the-minimally-invasive-treatment-of-adrenal-pathology" class="twitter">Twitter</a></li>
                            <li><a target="_blank" href="https://web.archive.org/web/20180712203526/https://www.linkedin.com/shareArticle?mini=true&amp;url=https://www.guideline.gov/summaries/summary/43951/guidelines-for-the-minimally-invasive-treatment-of-adrenal-pathology&amp;title=&amp;summary=&amp;source=" class="linkedin">Linkedin</a></li>
                            <li><a href="https://web.archive.org/web/20180712203526/mailto:/?Subject=AHRQ: Guidelines for the minimally invasive treatment of adrenal pathology.&amp;body=https://www.guideline.gov/summaries/summary/43951/guidelines-for-the-minimally-invasive-treatment-of-adrenal-pathology" class="email">Email</a></li>
                        </ul>
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
                <li class="dropdown tool">
                    <a href="#" class="tool-button">Cite</a>
                    <div class="dropdown-panel citation">
                        <p class="text-label"><label for="citation">Citation: </label></p>
                        <textarea id="citation">National Guideline Clearinghouse (NGC). Guideline summary: Guidelines for the minimally invasive treatment of adrenal pathology. In: National Guideline Clearinghouse (NGC) [Web site]. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ); 2013 Feb 01. [cited 2018 Jul 12]. Available: https://www.guideline.gov</textarea>                        
                        <p class="text-label">Download citation file: </p>
                        <ul>
                            <li><a href="/web/20180712203526/https://www.guideline.gov/summaries/citedownload/43951?format=ris">RIS (Zotero)</a></li>
                            <li><a href="/web/20180712203526/https://www.guideline.gov/summaries/citedownload/43951?format=enw">EndNote</a></li>
                            <li><a href="/web/20180712203526/https://www.guideline.gov/summaries/citedownload/43951?format=bibtex">BibTex</a></li>
                            <li><a href="/web/20180712203526/https://www.guideline.gov/summaries/citedownload/43951?format=txt">Medlars</a></li>
                            <li><a href="/web/20180712203526/https://www.guideline.gov/summaries/citedownload/43951?format=ris">ProCite</a></li>
                            <li><a href="/web/20180712203526/https://www.guideline.gov/summaries/citedownload/43951">RefWorks</a></li>
                            <li><a href="/web/20180712203526/https://www.guideline.gov/summaries/citedownload/43951?format=ris">Reference Manager</a></li>
                        </ul>
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
                                
                <li class="tool">
                        <a href="#" id="43951" data-alert="SignInLanding" class="tool-button save-link">Save</a>
                </li>
            </ul>

            <!-- Accordion -->
            <ul class="tools accordion-controls">
                <li class="tool"><a href="#" class="expand-all is-disabled" aria-disabled="true"><span class="screen-reader-text">Expand All</span></a></li>
                <li class="tool"><a href="#" class="collapse-all" aria-disabled="false"><span class="screen-reader-text">Collapse All</span></a></li>
            </ul>
        </div>
        <!-- /.toolbar -->


		<!-- ARTICLE -->
		<div class="article" id="article">
			




    <!-- ACCORDION -->
    <div class="accordion-container" role="tablist" multiselectable="true">
                <h2 id="420" class="accordion-title section-420 is-active" role="tab" aria-expanded="true"><a href="#">Recommendations</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Major Recommendations</a></h3>
                    <p><div class="content_para"><p>Definitions of the levels of evidence (<strong>+, ++, +++, ++++</strong>) and the grades of the recommendations (<strong>weak</strong> or <strong>strong</strong>) are provided at the end of the "Major Recommendations" field.</p>
<p><strong>Outcomes of Minimally Invasive Adrenalectomy</strong></p>
<p>Minimally invasive adrenalectomy is associated with less postoperative pain, shorter hospital stay, earlier recovery, and similar long-term outcomes compared with open surgery and has been established as the preferred approach to all non-primary adrenal cancer pathology (<strong>+++, strong</strong>).</p>
<p><strong>Adrenalectomy Techniques</strong></p>
<p>Several approaches to laparoscopic adrenalectomy (LA) have been described in the literature. Surgeons should choose the approach they are most familiar with, have had training in, and have the best patient outcomes with (<strong>+++, strong</strong>).</p>
<p>Surgeons should also take into consideration that in specific clinical circumstances some approaches may be more beneficial than others:</p>
<ul style="list-style-type: disc;">
    <li>In patients with previous abdominal surgery, a retroperitoneal approach may be associated with less operative time and fewer complications (<strong>++, weak</strong>). </li>
    <li>For bilateral adrenalectomies, the posterior retroperitoneal approach may be advantageous, as it eliminates patient repositioning during the case (<strong>++, weak</strong>). </li>
    <li>In morbidly obese patients (BMI &gt;35 kg/m<sup>2</sup>) and for large tumors (&gt;6 cm), the lateral transabdominal approach may increase the feasibility of the procedure compared with the other approaches (<strong>++, weak</strong>). </li>
</ul>
<p><strong>Robotic Adrenalectomy (RA)</strong></p>
<p>Compared with standard laparoscopic techniques, robotic adrenalectomy may offer advantages for large tumors and in morbidly obese patients (<strong>+, weak</strong>). However, given the increased cost, longer operative times, and lack of clear patient outcome benefits using this technique, additional higher quality evidence is needed before a firm recommendation can be provided.</p>
<p><strong>Single Port Adrenalectomy</strong></p>
<p>Based on the available evidence, single port adrenalectomy is feasible and safe when undertaken by an experienced surgeon but offers little if any advantage over other standard laparoscopic approaches to adrenalectomy. Additional, better quality evidence is needed before this approach can be recommended (<strong>+, weak</strong>).</p>
<p><strong>Partial Adrenalectomy</strong></p>
<p>Partial adrenalectomy is safe and feasible in the hands of appropriately trained surgeons. For patients requiring bilateral adrenalectomy, such as for hereditary pheochromocytomas, laparoscopic cortical sparing surgery may be the procedure of choice (<strong>++, weak</strong>).</p>
<p>Additional evidence is needed before a recommendation can be provided for partial adrenalectomy of single gland, non-hereditary tumors.</p>
<p><strong>Method and Timing for Taking the Adrenal Vein</strong></p>
<p>The classic teaching for early vein control during open adrenalectomy has not been confirmed for laparoscopic adrenalectomy, because patient outcomes do not appear to be affected by early versus late ligation. Thus, the type and timing of adrenal vein control depends on surgeon preference and the specific anatomic variables associated with each case (<strong>+, weak</strong>).</p>
<p><strong>Laparoscopic Adrenalectomy for Suspected or Proven Adrenal Cortical Carcinoma and Adrenal Metastases</strong></p>
<p>For adrenal cortical carcinoma (ACC), the best determinant of patient outcomes is an appropriate oncologic resection that includes <em>en bloc</em> resection of any contiguous involved structures and regional lymphadenectomy. Thus, an open approach to resection may be best. If a laparoscopic approach is chosen (due to unknown malignancy status preoperatively or suspected early stage ACC), conversion to open surgery is strongly recommended when difficult dissection is encountered due to tumor adhesion or invasion or enlarged lymph nodes are seen (<strong>++, strong</strong>).</p>
<p><strong>Adrenal Metastases</strong></p>
<p>Solitary metastases to the adrenal gland without evidence of local invasion can be approached laparoscopically by a surgeon skilled in advanced laparoscopy and adrenal surgery (<strong>+, weak</strong>). If local invasion is found intraoperatively, conversion to an open approach is warranted (<strong>+, strong</strong>).</p>
<p><strong>Laparoscopic Adrenalectomy in Large Adrenal Masses</strong></p>
<p>Large adrenal tumors without pre- or intraoperative evidence of primary adrenal cortical carcinoma can be approached laparoscopically by a surgeon skilled in advanced laparoscopy and adrenal surgery (<strong>+, weak</strong>). Laparoscopic adrenalectomy for larger tumors may be associated with increased operating room times, blood loss, and conversion rate to open surgery (<strong>+, weak</strong>). If there is any evidence for carcinoma found intraoperatively, conversion to an open approach is warranted (should be strongly considered) (<strong>+, strong</strong>).</p>
<p><strong>Pheochromocytoma</strong></p>
<p><em>Preoperative Care</em></p>
<p>Before laparoscopic adrenalectomy for pheochromocytoma, alpha adrenergic receptor blockade should be considered in all patients. When used preoperatively, alpha blockade should be continued until signs of orthostatic hypotension are evident (<strong>+++, weak</strong>). Short acting alpha blockers may be preferable to long acting ones. Beta blockade should also be considered in appropriately selected patients and should only be instituted following adequate alpha blockade (<strong>++, weak</strong>).</p>
<p><em>Intraoperative Management</em></p>
<p>Invasive hemodynamic monitoring should be considered during LA for pheochromocytomas (<strong>++, strong</strong>). To minimize hemodynamic instability due to catecholamine release during surgery, minimization of direct manipulation or compression of the adrenal gland is necessary (<strong>++, strong</strong>). Early ligation of the vein does not prevent hemodynamic instability (<strong>+, weak</strong>). Due to the added challenge of intraoperative hemodynamic variability, frequent communication between the surgical and anesthesia teams is important for optimal perioperative outcomes.</p>
<p><em>Postoperative Management</em></p>
<p>Due to the potential for hemodynamic instability after pheochromocytoma resection, all patients should be closely monitored in the early postoperative phase (<strong>++, strong</strong>). Capsular disruptions of the adrenal gland during surgery should be avoided to minimize the risk of disease recurrence. (<strong>+, weak)</strong>. Given the lack of clear predictors of malignancy to detect recurrences, patients with pheochromocytoma should be monitored long term with blood pressure measurements and serum and/or urinary metanephrine levels (<strong>++, strong</strong>).</p>
<p><strong>Learning Curve</strong></p>
<p>Minimally invasive adrenalectomy is associated with a learning curve that may be difficult to overcome given the paucity of these cases in general practice. Dedicated, advanced training should be pursued by surgeons unfamiliar with this technique. Until proficiency with laparoscopic adrenalectomy is attained, consideration should be given to referral to a center with expertise in minimally-invasive adrenal surgery (<strong>++, strong</strong>).</p>
<p><strong><span style="text-decoration: underline;">Definitions</span></strong>:</p>
<p><strong>Quality of Evidence</strong></p>
<p>Both the quality of the evidence and the strength of the recommendation for each of the guidelines were assessed according to the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system.* There is a 4-tiered system for quality of evidence:</p>
<table border="1" cellspacing="1" cellpadding="3" summary="Table: Quality of Evidence">
    <thead>
        <tr>
            <th valign="top">Quality of Evidence</th>
            <th valign="top">Definition</th>
            <th valign="top">Symbol Used</th>
        </tr>
    </thead>
    <tbody>
        <tr>
            <td valign="top">High quality</td>
            <td valign="top">Further research is very unlikely to alter confidence in the estimate of impact</td>
            <td valign="top">++++</td>
        </tr>
        <tr>
            <td valign="top">Moderate quality</td>
            <td valign="top">Further research is likely to alter confidence in the estimate of impact and may change the estimate</td>
            <td valign="top">+++</td>
        </tr>
        <tr>
            <td valign="top">Low quality</td>
            <td valign="top">Further research is very likely to alter confidence in the estimate of impact and is likely to change the estimate</td>
            <td valign="top">++</td>
        </tr>
        <tr>
            <td valign="top">Very low quality</td>
            <td valign="top">Any estimate of impact is uncertain</td>
            <td valign="top">+</td>
        </tr>
    </tbody>
</table>
<p><strong>Strength of Recommendations</strong></p>
<p>There is a 2-tiered system for strength of recommendation (weak or strong):</p>
<p><strong>Strong</strong>: It is very certain that benefit exceeds risk for the option considered</p>
<p><strong>Weak</strong>: Risk and benefit well balanced, patients in differing clinical situations would make different choices, or benefits available but not certain.</p>
<p class="Note">*Adapted from Guyatt GH, Oxman AD, Vist GE, et al; GRADE Working Group. GRADE: An emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008; 336:924-6.</p></div></p>
                        <h3><a href="#">Clinical Algorithm(s)</a></h3>
                    <p><div class="content_para"><p>None provided</p></div></p>

            </div>
                <h2 id="396" class="accordion-title section-396 is-active" role="tab" aria-expanded="true"><a href="#">Scope</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Disease/Condition(s)</a></h3>
                    <p><div class="content_para"><p>Adrenal disease</p></div></p>
                        <h3><a href="#">Guideline Category</a></h3>
                    <p>Assessment of Therapeutic Effectiveness</p>
                    <p>Evaluation</p>
                    <p>Management</p>
                    <p>Risk Assessment</p>
                    <p>Treatment</p>
                        <h3><a href="#">Clinical Specialty</a></h3>
                    <p>Endocrinology</p>
                    <p>Oncology</p>
                    <p>Surgery</p>
                    <p>Urology</p>
                        <h3><a href="#">Intended Users</a></h3>
                    <p>Patients</p>
                    <p>Physicians</p>
                        <h3><a href="#">Guideline Objective(s)</a></h3>
                    <p><div class="content_para"><p>To provide systematically developed statements to educate and guide the surgeon (and patient) in the appropriate use of minimally invasive techniques for the treatment of adrenal disease</p></div></p>
                        <h3><a href="#">Target Population</a></h3>
                    <p><div class="content_para"><p>Patients with adrenal disease, including functional and nonfunctional adrenal tumors</p>
<p class="Note"><strong>Note</strong>: A description of the presenting symptoms of adrenal disease and their diagnostic workup is beyond the scope of this guideline. The focus of the current guideline begins after the decision to perform an adrenalectomy has been made.</p></div></p>
                        <h3><a href="#">Interventions and Practices Considered</a></h3>
                    <p><ol style="list-style-type: decimal;" start="1">
    <li>Lateral transabdominal adrenalectomy (LTA) </li>
    <li>Posterior retroperitoneoscopic adrenalectomy (PRA) </li>
    <li>Anterior transabdominal adrenalectomy (ATA) </li>
    <li>Lateral retroperitoneoscopic adrenalectomy (LPA) </li>
    <li>Robotic adrenalectomy (RA) </li>
    <li>Single port adrenalectomy </li>
    <li>Partial adrenalectomy </li>
    <li>Laparoscopy </li>
</ol></p>
                        <h3><a href="#">Major Outcomes Considered</a></h3>
                    <p><ul style="list-style-type: disc;">
    <li>Survival </li>
    <li>Local and overall recurrence </li>
    <li>Postoperative pain </li>
    <li>Time of convalescence </li>
    <li>Cosmesis </li>
</ul></p>

            </div>
                <h2 id="405" class="accordion-title section-405 is-active" role="tab" aria-expanded="true"><a href="#">Methodology</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Methods Used to Collect/Select the Evidence</a></h3>
                    <p>Searches of Electronic Databases</p>
                        <h3><a href="#">Description of Methods Used to Collect/Select the Evidence</a></h3>
                    <p><div class="content_para"><p>A systematic literature search was performed on MEDLINE in April 2011. The search strategy was limited to adult English language articles (shown in Figure 1 in the original document).</p>
<p>The literature search identified 79 relevant articles. The abstracts were reviewed by four committee members and divided into the following categories:</p>
<ul style="list-style-type: disc;">
    <li>Randomized studies, meta-analyses, and systematic reviews </li>
    <li>Prospective studies </li>
    <li>Retrospective studies </li>
    <li>Case reports </li>
    <li>Review articles </li>
</ul>
<p>Randomized controlled trials, meta-analyses, and systematic reviews were selected for further review along with prospective and retrospective studies when a higher level of evidence was lacking. For inclusion, prospective and retrospective studies had to report outcomes on at least 50 adrenalectomies. Studies with smaller samples were considered when additional evidence was lacking. The most recent reviews were also included. All case reports, old reviews, and smaller studies were excluded. Duplicate publications or patient populations were considered only once. Whenever the available evidence from Level I studies was considered to be adequate, lower evidence level studies were not considered. Newer relevant articles that were published after the original literature search date during the drafting of this guideline were also included. According to these exclusion criteria, 70 articles were selected for review.</p></div></p>
                        <h3><a href="#">Number of Source Documents</a></h3>
                    <p><div class="content_para"><p>164 articles</p></div></p>
                        <h3><a href="#">Methods Used to Assess the Quality and Strength of the Evidence</a></h3>
                    <p>Weighting According to a Rating Scheme (Scheme Given)</p>
                        <h3><a href="#">Rating Scheme for the Strength of the Evidence</a></h3>
                    <p><div class="content_para"><p><strong>Quality of Evidence</strong></p>
<p>Both the quality of the evidence and the strength of the recommendation for each of the guidelines were assessed according to the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system.* There is a 4-tiered system for quality of evidence:</p>
<table border="1" cellspacing="1" cellpadding="3" summary="Table: Quality of Evidence">
    <thead>
        <tr>
            <th valign="top">Quality of Evidence</th>
            <th valign="top">Definition</th>
            <th valign="top">Symbol Used</th>
        </tr>
    </thead>
    <tbody>
        <tr>
            <td valign="top">High quality</td>
            <td valign="top">Further research is very unlikely to alter confidence in the estimate of impact</td>
            <td valign="top">++++</td>
        </tr>
        <tr>
            <td valign="top">Moderate quality</td>
            <td valign="top">Further research is likely to alter confidence in the estimate of impact and may change the estimate</td>
            <td valign="top">+++</td>
        </tr>
        <tr>
            <td valign="top">Low quality</td>
            <td valign="top">Further research is very likely to alter confidence in the estimate of impact and is likely to change the estimate</td>
            <td valign="top">++</td>
        </tr>
        <tr>
            <td valign="top">Very low quality</td>
            <td valign="top">Any estimate of impact is uncertain</td>
            <td valign="top">+</td>
        </tr>
    </tbody>
</table>
<p class="Note">*Adapted from Guyatt GH, Oxman AD, Vist GE, et al; GRADE Working Group. GRADE: An emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008; 336:924-6.</p></div></p>
                        <h3><a href="#">Methods Used to Analyze the Evidence</a></h3>
                    <p>Systematic Review</p>
                        <h3><a href="#">Description of the Methods Used to Analyze the Evidence</a></h3>
                    <p><div class="content_para"><p>The reviewers graded the level of evidence and searched the bibliography of each article for additional articles that may have been missed during the original search. Additional relevant articles (n=94) were obtained and included in the review for grading. A total of 164 graded articles relevant to this guideline were included in this review. To facilitate the review by multiple reviewers, these articles were divided into the following topics and distributed to the reviewers:</p>
<ul style="list-style-type: disc;">
    <li>Minimally invasive adrenalectomy outcomes and comparison to open </li>
    <li>Description and comparison of various minimally invasive surgery (MIS) adrenalectomy techniques </li>
    <li>Management of large adrenal tumors </li>
    <li>Management of adrenal cortical carcinoma and metastatic disease </li>
    <li>Management of pheochromocytoma </li>
    <li>Other circumstances (i.e., partial and bilateral adrenalectomy, etc.) </li>
</ul></div></p>
                        <h3><a href="#">Methods Used to Formulate the Recommendations</a></h3>
                    <p>Expert Consensus</p>
                        <h3><a href="#">Description of Methods Used to Formulate the Recommendations</a></h3>
                    <p><div class="content_para"><p>The recommendations included in this guideline were devised based on the reviewers' grading of all articles.</p></div></p>
                        <h3><a href="#">Rating Scheme for the Strength of the Recommendations</a></h3>
                    <p><div class="content_para"><p>Both the quality of the evidence and the strength of the recommendation for each of the guidelines were assessed according to the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system.*</p>
<p>There is a 2-tiered system for strength of recommendation (<strong>weak</strong> or <strong>strong</strong>):</p>
<p><strong>Strength of Recommendations</strong></p>
<p><strong>Strong</strong>: It is very certain that benefit exceeds risk for the option considered</p>
<p><strong>Weak</strong>: Risk and benefit well balanced, patients in differing clinical situations would make different choices, or benefits available but not certain</p>
<p class="Note">*Adapted from Guyatt GH, Oxman AD, Vist GE, et al; GRADE Working Group. GRADE: An emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008; 336:924-6.</p></div></p>
                        <h3><a href="#">Cost Analysis</a></h3>
                    <p><div class="content_para"><p>A formal cost analysis was not performed and published cost analyses were not reviewed.</p></div></p>
                        <h3><a href="#">Method of Guideline Validation</a></h3>
                    <p>Internal Peer Review</p>
                        <h3><a href="#">Description of Method of Guideline Validation</a></h3>
                    <p><div class="content_para"><p>Guidelines were developed under the auspices of Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), the guidelines committee, and were approved by the Board of Governors. The recommendations of each guideline underwent multidisciplinary review. The recommendations of each guideline undergo multidisciplinary review and are considered valid at the time of production based on the data available. New developments in medical research and practice pertinent to each guideline are reviewed, and guidelines will be periodically updated.</p></div></p>

            </div>
                <h2 id="424" class="accordion-title section-424 is-active" role="tab" aria-expanded="true"><a href="#">Evidence Supporting the Recommendations</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Type of Evidence Supporting the Recommendations</a></h3>
                    <p><div class="content_para"><p>The type of supporting evidence is identified and graded for each recommendation (see the "Major Recommendations" field).</p></div></p>

            </div>
                <h2 id="427" class="accordion-title section-427 is-active" role="tab" aria-expanded="true"><a href="#">Benefits/Harms of Implementing the Guideline Recommendations</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Potential Benefits</a></h3>
                    <p><ul style="list-style-type: disc;">
    <li>Appropriate use of minimally invasive techniques for the treatment of adrenal disease </li>
    <li>Comparative studies with other laparoscopic approaches have demonstrated a small yet significant benefit in pain medication requirement, time to oral intake, length of hospital stay, and overall convalescence for posterior retroperitoneoscopic adrenalectomy (PRA) </li>
</ul></p>
                        <h3><a href="#">Potential Harms</a></h3>
                    <p><ul style="list-style-type: disc;">
    <li>Typically, the lateral retroperitoneoscopic adrenalectomy procedure has slightly longer operating times and requires more ports than laparoscopic adrenalectomy (LA) or posterior retroperitoneoscopic adrenalectomy (PRA) </li>
    <li>Robotic adrenalectomy includes increased cost, longer operative times, and lack of clear patient outcome benefits. </li>
    <li>LA of large tumors has been shown to be an independent risk factor for longer operating times, more blood loss, longer hospital stay, and a higher conversion rate to open surgery </li>
</ul>
<p><strong>Pheochromocytoma Resection</strong></p>
<ul style="list-style-type: disc;">
    <li>In addition to the problems associated with catecholamine liberation, large size and prominent vascularity compound the challenges of removing pheochromocytomas. Compared with other indications for adrenalectomy, both laparoscopic and open resection of pheochromocytomas has been associated with longer operative times, higher complication rates, greater blood loss <br/>
    and longer hospitalization. </li>
    <li>In general, these tumors tend to be larger than other functional and nonfunctional adrenal lesions and often have a large number of arterial and venous tributaries that bleed with minimal manipulation. The renal vessels must be carefully identified and protected to avoid inadvertent injury during dissection. </li>
    <li>Intraoperative hypertension and hypotension can occur during intraoperative management, leading to hemodynamic instability. </li>
</ul></p>

            </div>
                <h2 id="432" class="accordion-title section-432 is-active" role="tab" aria-expanded="true"><a href="#">Qualifying Statements</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Qualifying Statements</a></h3>
                    <p><div class="content_para"><p>Clinical practice guidelines are intended to indicate the best available approach to medical conditions as established by a systematic review of available data and expert opinion. The approach suggested might not be the only acceptable approach given the complexity of the healthcare environment. These guidelines are intended to be flexible, as the surgeon must choose the approach best suited to the individual patient and variables in existence at the moment of decision. These guidelines are applicable to all physicians who are appropriately credentialed and address the clinical situation in question, regardless of specialty.</p></div></p>

            </div>
                <h2 id="434" class="accordion-title section-434 is-active" role="tab" aria-expanded="true"><a href="#">Implementation of the Guideline</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Description of Implementation Strategy</a></h3>
                    <p><div class="content_para"><p>An implementation strategy was not provided.</p></div></p>

            </div>
                <h2 id="439" class="accordion-title section-439 is-active" role="tab" aria-expanded="true"><a href="#">Institute of Medicine (IOM) National Healthcare Quality Report Categories</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">IOM Care Need</a></h3>
                    <p>Getting Better</p>
                    <p>Living with Illness</p>
                        <h3><a href="#">IOM Domain</a></h3>
                    <p>Effectiveness</p>
                    <p>Patient-centeredness</p>

            </div>
                <h2 id="442" class="accordion-title section-442 is-active" role="tab" aria-expanded="true"><a href="#">Identifying Information and Availability</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Bibliographic Source(s)</a></h3>
                    <p><table><tr><td>Society of American Gastrointestinal Endoscopic Surgeons (SAGES). Guidelines for the minimally invasive treatment of adrenal pathology. Los Angeles (CA): Society of American Gastrointestinal Endoscopic Surgeons (SAGES); 2013 Feb. 27 p.  [164 references]</td></tr></table></p>
                        <h3><a href="#">Adaptation</a></h3>
                    <p><div class="content_para"><p>Not applicable: The guideline was not adapted from another source.</p></div></p>
                        <h3><a href="#">Date Released</a></h3>
                    <p>2013 Feb</p>
                        <h3><a href="#">Guideline Developer(s)</a></h3>
                    <p>Society of American Gastrointestinal and Endoscopic Surgeons - Medical Specialty Society</p>
                        <h3><a href="#">Source(s) of Funding</a></h3>
                    <p><div class="content_para"><p>Society of American Gastrointestinal and Endoscopic Surgeons (SAGES)</p></div></p>
                        <h3><a href="#">Guideline Committee</a></h3>
                    <p><div class="content_para"><p>Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) Guideline Committee</p></div></p>
                        <h3><a href="#">Composition of Group That Authored the Guideline</a></h3>
                    <p><div class="content_para"><p><em>Committee Members</em>: Dimitrios Stefanidis (<em>Corresponding Author</em>), MD, PhD, Carolinas Medical Center, Charlotte, NC; Melanie Goldfarb, MD: University of Southern California, Keck School of Medicine, Los Angeles, CA; Kent W. Kercher, MD, Carolinas Medical Center, Charlotte, NC; William W. Hope, MD, South East Area Health Education Center, Wilmington, NC; William Richardson, MD, Ochsner Clinic Foundation, New Orleans, LA; Robert D. Fanelli, MD: Berkshire Medical Center, Pittsfield, MA</p></div></p>
                        <h3><a href="#">Financial Disclosures/Conflicts of Interest</a></h3>
                    <p><div class="content_para"><p>Society of American Gastrointestinal Endoscopic Surgeons (SAGES) leadership members, committee members, and guidelines authors disclose real and potential conflicts on a yearly basis and whenever they change, and real and potential conflicts are mitigated through mechanisms approved by the SAGES Conflict of Interest Task Force.</p></div></p>
                        <h3><a href="#">Guideline Status</a></h3>
                    <p><div class="content_para"><p>This is the current release of the guideline.</p></div></p>
                        <h3><a href="#">Guideline Availability</a></h3>
                    <p><div class="content_para"><p>Electronic copies: Available from the <a href="/web/20180712203526/https://www.guideline.gov/Home/Disclaimer?id=43951&amp;contentType=summary&amp;redirect=http%3a%2f%2fwww.sages.org%2fpublications%2fguidelines%2fguidelines-for-the-minimally-invasive-treatment-of-adrenal-pathology%2f" title="SAGES Web site">Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712203526im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>.</p>
<p>Print copies: Available from the Society of American Gastrointestinal Endoscopic Surgeons (SAGES), 11300 W. Olympic Blvd., Suite 600, Los Angeles, CA 90064; Web site: <a href="/web/20180712203526/https://www.guideline.gov/Home/Disclaimer?id=43951&amp;contentType=summary&amp;redirect=http%3a%2f%2fwww.sages.org" title="SAGES Web site">www.sages.org</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712203526im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>.</p></div></p>
                        <h3><a href="#">Availability of Companion Documents</a></h3>
                    <p><div class="content_para"><p>None available</p></div></p>
                        <h3><a href="#">Patient Resources</a></h3>
                    <p><div class="content_para"><p>None available</p></div></p>
                        <h3><a href="#">NGC Status</a></h3>
                    <p><div class="content_para"><p>This NGC summary was completed by ECRI Institute on May 3, 2013. This summary was updated by ECRI Institute on February 15, 2017 following the U.S. Food and Drug Administration advisory on general anesthetic and sedation drugs.</p></div></p>
                        <h3><a href="#">Copyright Statement</a></h3>
                    <p><div class="content_para"><p>This NGC summary is based on the original guideline, which is subject to the guideline developer's copyright restrictions.</p></div></p>

            </div>
                <h2 id="99999" class="accordion-title section-99999 is-active" role="tab" aria-expanded="true"><a href="#">Disclaimer</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">NGC Disclaimer</a></h3>
                    <p><p>The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.</p> 
<p>All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.</p> 
<p>Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the <a href="/web/20180712203526/https://www.guideline.gov/help-and-about/summaries/inclusion-criteria">NGC Inclusion Criteria</a>.</p> 
<p>NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.</p> 
<p>Readers with questions regarding guideline content are directed to contact the guideline developer.</p></p>

            </div>

    </div>
    <!-- /.accordion-container -->

<!-- ASIDE -->
<!-- FOOTER -->






		</div><!-- /.article -->

	</div><!-- /.content -->

	
			<div class="aside">
				

    <!-- About NGC -->
    <div class="info-block">
            <h3 class="info prefix-icon large-icon">About NGC Guideline Summaries</h3>
            <p>NGC provides structured summaries containing information from clinical practice guidelines.</p>
            <ul>
                <li><a href="/web/20180712203526/https://www.guideline.gov/help-and-about/summaries/inclusion-criteria" class="internal-link">Inclusion Criteria</a></li>
                <li><a href="/web/20180712203526/https://www.guideline.gov/help-and-about/summaries/template-of-guideline-attributes" class="internal-link">Template of Guideline Attributes</a></li>
                <li><a href="/web/20180712203526/https://www.guideline.gov/help-and-about/summaries/classification-scheme" class="internal-link">Classification Scheme</a></li>
            </ul>
            <p><a href="/web/20180712203526/https://www.guideline.gov/help-and-about/summaries/faqs" class="help-button">Guideline Summary FAQs</a></p>

    </div>
    <!-- /info-block -->

    <!-- Guideline Synthesis -->

    <!-- HHS Block -->

    <!-- Related Content -->


    <hr>

    <!-- New on NGC -->
    <div class="subscribe-header">
        <h3 class="subscribe-title">New on NGC</h3>
        <ul class="subscribe-links">
            <li><a href="/web/20180712203526/https://www.guideline.gov/subscribe" class="newsletter"><span class="subscribe-links-label">Get Email Alerts</span></a></li>
            <li><a href="/web/20180712203526/https://www.guideline.gov/rssFiles/ngc_newthisweek.xml" class="rss"><span class="subscribe-links-label">RSS Feed</span></a></li>
        </ul>
    </div>
    <!-- /.subscribe-header -->
        <h5 class="prefix-icon guideline news-list-category-label">Guideline Summaries</h5>
        <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011378</li>
            <li>2017 Oct</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712203526/https://www.guideline.gov/summaries/summary/51300/mental-health-care-in-the-perinatal-period-australian-clinical-practice-guideline">Mental health care in the perinatal period: Australian clinical practice guideline.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011372</li>
            <li>2015</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712203526/https://www.guideline.gov/summaries/summary/51294/clinical-practice-guideline-on-systemic-lupus-erythematosus">Clinical practice guideline on systemic lupus erythematosus.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011385</li>
            <li>2018 Mar</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712203526/https://www.guideline.gov/summaries/summary/51326/vadod-clinical-practice-guideline-for-the-management-of-pregnancy">VA/DoD clinical practice guideline for the management of pregnancy.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011376</li>
            <li>2018 Feb</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712203526/https://www.guideline.gov/summaries/summary/51298/clinical-pharmacogenetics-implementation-consortium-cpic-guideline-for-dihydropyrimidine-dehydrogenase-genotype-and-fluoropyrimidine-dosing-2017-update">Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing: 2017 update.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011370</li>
            <li>2017 Dec</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712203526/https://www.guideline.gov/summaries/summary/51292/the-implementation-of-targeted-temperature-management-an-evidencebased-guideline-from-the-neurocritical-care-society">The implementation of targeted temperature management: an evidence-based guideline from the Neurocritical Care Society.</a></p>
    </div>

    <a class="block-link" href="/web/20180712203526/https://www.guideline.gov/new-this-week/index">
        <h3>New This Week </h3>
        <p>View more and sign up for our Newsletter</p>
    </a>
    <!-- Adobe Reader -->
    <p><a href="/web/20180712203526/https://www.guideline.gov/disclaimer?id=43951&amp;contentType=summary&amp;redirect=http%3A%2F%2Fget.adobe.com%2Freader%2F" class="external-link">Get Adobe Reader</a></p>

			</div><!-- /.aside -->
		</div><!-- /.aside-container -->

	<!-- BACK TO TOP -->
	
	
	



    <!-- COMMENTS -->
    

</div><!-- /.main -->

	</main>

	<!-- FOOTER -->
	<div class="footer" id="footer">

		<div class="footer-grid-container">
			<!-- Header -->
			<div class="footer-header">
				<a href="#" class="footer-logo">
			 		<picture>
					  	<source type="image/svg+xml" srcset="/web/20180712203526im_/https://www.guideline.gov/UI/images/logo_NGC_footer.svg">
					  	<img src="/web/20180712203526im_/https://www.guideline.gov/UI/images/logo_NGC_footer.png" alt="NGC">
					</picture>
				</a>
			</div><!-- /.footer-header -->

			<!-- Content -->
			<div class="footer-content">
				<div class="footer-nav">
					<ul class="level-1">
						<li><a href="/web/20180712203526/https://www.guideline.gov/">Home</a></li>
		                <li><a href="/web/20180712203526/https://www.guideline.gov/new-this-week/index">New This Week</a></li>
						<li><a href="/web/20180712203526/https://www.guideline.gov/browse/organization" class="parent-link">Guideline Summaries</a></li>
<li><a href="/web/20180712203526/https://www.guideline.gov/syntheses/index">Guideline Syntheses</a></li>						<li><a href="/web/20180712203526/https://www.guideline.gov/expert">Expert Commentaries</a></li>
		                <li><a href="/web/20180712203526/https://www.guideline.gov/matrix">Matrix Tool</a></li>
						<li><a href="/web/20180712203526/https://www.guideline.gov/summaries/submit">Submit Guidelines</a></li>
						<li><a href="/web/20180712203526/https://www.guideline.gov/help-and-about">Help &amp;&nbsp;About</a></li>
					</ul>
					<ul class="level-2">
						<li><a href="/web/20180712203526/https://www.guideline.gov/contact-us">Contact Us</a></li>
						<li><a href="/web/20180712203526/https://www.guideline.gov/rss">RSS</a></li>
					    <li><a href="/web/20180712203526/https://www.guideline.gov/site-map">Site Map</a></li>
                        <li><a href="/web/20180712203526/https://www.guideline.gov/browse/related">Related NQMC Measures</a></li>
                        <li><a href="/web/20180712203526/https://www.guideline.gov/help-and-about/about/editorial-board">Editorial Board</a></li>
                        <li><a href="/web/20180712203526/https://www.guideline.gov/help-and-about/general/web-site-credits">Web Site Credits</a></li>
                        <li><a href="/web/20180712203526/https://www.guideline.gov/help-and-about/general/disclaimer">Disclaimer</a></li>
						<li><a href="/web/20180712203526/https://www.guideline.gov/help-and-about/general/privacy">Privacy Policy</a></li>
                        <li><a href="/web/20180712203526/https://www.guideline.gov/help-and-about/technical/accessibility">Accessibility</a></li>	
                        <li><a href="/web/20180712203526/https://www.guideline.gov/help-and-about/technical/for-web-developers">For Web Developers</a></li>
					</ul>
				</div><!-- /.footer-nav -->
			</div><!-- /.footer-content -->

			<!-- Aside -->
			<div class="footer-aside">
				<h5 class="footer-partner-link-header">Visit our partner sites</h5>
				<ul class="footer-partner-links">
				    <li><!-- NQMC footer link -->
						<a href="https://web.archive.org/web/20180712203526/https://www.qualitymeasures.ahrq.gov/" target="_blank" class="partner-button nqmc">
							<span class="partner-logo">
								<picture>
							    	<source type="image/svg+xml" srcset="/web/20180712203526im_/https://www.guideline.gov/UI/images/logo_footerlink_nqmc.svg">
									<img src="/web/20180712203526im_/https://www.guideline.gov/UI/images/logo_footerlink_nqmc.png" alt="National Quality Measures Clearinghouse"/>
								</picture>
							</span>
						</a>
					</li><!--/MQMC footer Link -->
					<li><!-- HHS footer link --> 
						<a href="https://web.archive.org/web/20180712203526/https://www.qualitymeasures.ahrq.gov/hhs/index.aspx" target="_blank" class="partner-button hhs">
							<span class="partner-logo">
								<picture>
								    <source type="image/svg+xml" srcset="/web/20180712203526im_/https://www.guideline.gov/UI/images/logo_footerlink_hmis.svg">
								    <img src="/web/20180712203526im_/https://www.guideline.gov/UI/images/logo_footerlink_hmis.png" alt="HHS Measures Inventory"/>
								</picture>
							</span>
						</a>
					</li><!--/HHS footer link -->
				</ul>
			</div><!-- /.footer-aside -->

		</div><!-- /.footer-grid-container -->

	</div><!-- /.footer -->

	
	<!-- AHRQ FOOTER -->
	<div id="ahrq-footer">

		<!-- FIRST -->
		<div class="ahrq-first-footer">
			<div class="column">
			<div class="ahrq-footer-grid-container">
				<div class="ahrq-footer-left">
					<p><a href="https://web.archive.org/web/20180712203526/http://www.ahrq.gov/index.html" class="ahrq-footer-logo" target="_blank">AHRQ</a></p>
				</div><!-- /.ahrq-footer-left -->
				<div class="ahrq-footer-center">
					<ul>
						<li><a href="https://web.archive.org/web/20180712203526/http://www.ahrq.gov/policy/electronic/accessibility/index.html" target="_blank">Accessibility</a></li>
						<li><a href="https://web.archive.org/web/20180712203526/http://www.ahrq.gov/policy/electronic/disclaimers/index.html" target="_blank">Disclaimers</a></li>
						<li><a href="https://web.archive.org/web/20180712203526/http://www.ahrq.gov/policy/eeo/index.html" target="_blank">EEO</a></li>
						<li><a href="https://web.archive.org/web/20180712203526/http://www.ahrq.gov/policy/foia/index.html" target="_blank">FOIA</a></li>
						<li><a href="https://web.archive.org/web/20180712203526/http://www.hhs.gov/web/governance/digital-strategy/index.html" target="_blank">HHS Digital Strategy</a></li>
						<li><a href="https://web.archive.org/web/20180712203526/http://oig.hhs.gov/" target="_blank">Inspector General</a></li>
						<li><a href="https://web.archive.org/web/20180712203526/http://www.ahrq.gov/policy/electronic/plain-writing/index.html" target="_blank">Plain Writing Act</a></li>
						<li><a href="https://web.archive.org/web/20180712203526/http://www.ahrq.gov/policy/electronic/privacy/index.html" target="_blank">Privacy Policy</a></li>
						<li><a href="https://web.archive.org/web/20180712203526/http://www.ahrq.gov/policy/electronic/about/policyix.html" target="_blank">Electronic Policies</a></li>
						<li><a href="https://web.archive.org/web/20180712203526/http://www.hhs.gov/plugins.html" target="_blank">Viewers &amp; Players</a></li>
					</ul>
				</div><!-- /.ahrq-footer-center -->
				<div class="ahrq-footer-right">
					<h3>Get Social</h3>
					<ul class="ahrq-social">
						<li><a href="https://web.archive.org/web/20180712203526/http://www.facebook.com/" target="_blank" class="facebook"><span class="screen-reader-text">Facebook</span></a></li>
						<li><a href="https://web.archive.org/web/20180712203526/http://www.twitter.com/" target="_blank" class="twitter"><span class="screen-reader-text">Twitter</span></a></li>
						<li><a href="https://web.archive.org/web/20180712203526/http://www.linkedin.com/" target="_blank" class="linkedin"><span class="screen-reader-text">LinkedIn</span></a></li>
						<li><a href="https://web.archive.org/web/20180712203526/http://www.youtube.com/" target="_blank" class="youtube"><span class="screen-reader-text">YouTube</span></a></li>
					</ul>
				</div><!-- /.ahrq-footer-right -->
			</div><!-- /.ahrq-footer-grid-container -->
			</div><!-- /.column -->
		</div><!-- /.first-footer -->

		<!-- SECOND -->
		<div class="ahrq-second-footer">
			<div class="column">
			<div class="ahrq-footer-grid-container">
				<div class="ahrq-footer-left">
					<ul>
						<li><a href="https://web.archive.org/web/20180712203526/http://www.ahrq.gov/index.html" target="_blank" class="ahrq-footer-home-link"><span class="screen-reader-text">AHRQ Home</span></a></li>
						<li><a href="https://web.archive.org/web/20180712203526/http://www.ahrq.gov/cpi/about/index.html" target="_blank">About Us</a></li>
						<li><a href="https://web.archive.org/web/20180712203526/http://www.ahrq.gov/cpi/about/careers/index.html" target="_blank">Careers</a></li>
						<li><a href="https://web.archive.org/web/20180712203526/http://www.ahrq.gov/contact/index.html" target="_blank">Contact Us</a></li>
						<li><a href="https://web.archive.org/web/20180712203526/http://www.ahrq.gov/Sitemap.html" target="_blank">Sitemap</a></li>
						<li><a href="https://web.archive.org/web/20180712203526/https://info.ahrq.gov/" target="_blank">FAQ</a></li>
					</ul>	
				</div><!-- /.ahrq-footer-left -->
				<div class="ahrq-footer-center">
					<ul>
						<li><a href="https://web.archive.org/web/20180712203526/http://www.ahrq.gov/health-care-information/index.html" target="_blank">Health Care Information</a></li>
						<li><a href="https://web.archive.org/web/20180712203526/http://www.ahrq.gov/patients-consumers/index.html" target="_blank">For Patients &amp; Consumers</a></li>
						<li><a href="https://web.archive.org/web/20180712203526/http://www.ahrq.gov/professionals/index.html" target="_blank">For Professionals</a></li>
						<li><a href="https://web.archive.org/web/20180712203526/http://www.ahrq.gov/policymakers/index.html" target="_blank">For Policymakers</a></li>
						<li><a href="https://web.archive.org/web/20180712203526/http://www.ahrq.gov/research/index.html" target="_blank">Research Tools &amp; Data</a></li>
						<li><a href="https://web.archive.org/web/20180712203526/http://www.ahrq.gov/funding/index.html" target="_blank">Funding &amp; Grants</a></li>
						<li><a href="https://web.archive.org/web/20180712203526/http://www.ahrq.gov/cpi/index.html" target="_blank">Offices, Centers &amp; Programs</a></li>
						<li><a href="https://web.archive.org/web/20180712203526/http://www.ahrq.gov/news/index.html" target="_blank">News &amp; Events</a></li>
					</ul>
				</div><!-- /.ahrq-footer-center -->
				<div class="ahrq-footer-right">
					<ul>
						<li><a href="https://web.archive.org/web/20180712203526/http://www.hhs.gov/" target="_blank">U.S. Department of Health &amp; Human Services</a></li>
						<li><a href="https://web.archive.org/web/20180712203526/http://www.whitehouse.gov/" target="_blank">The White House</a></li>
						<li><a href="https://web.archive.org/web/20180712203526/http://www.usa.gov/" target="_blank">USA.gov: The U.S. Government's Official Web Portal   </a></li>
					</ul>
					<p class="ahrq-address">
						<strong>Agency for Healthcare Research&nbsp;and&nbsp;Quality</strong>
					    <br/>5600 Fishers Lane
					    <br/>Rockville, MD 20857
					    <br/><strong>Telephone:</strong> (301) 427-1364
					</p>
				</div><!-- /.ahrq-footer-right -->
			</div><!-- /.ahrq-footer-grid-container -->
			</div><!-- /.column -->
		</div><!-- /.second-footer -->
	</div><!-- /#ahrq-footer -->


	
	<!-- SCRIPTS -->
	
<script src="//web.archive.org/web/20180712203526js_/https://ajax.googleapis.com/ajax/libs/jquery/1.6.3/jquery.min.js" type="text/javascript"></script>
<script type="text/javascript">
if(!window.jQuery){
document.write('<script src="/cassette.axd/script/cdd67f922f9d413eaccb759182297335f87c3ff7/UI/js/jquery.js" type="text/javascript"><\/script>');
}
</script>
<script src="/web/20180712203526js_/https://www.guideline.gov/cassette.axd/script/595952c286b7fd52f0737b6f62085709be93156a/bodyJS" type="text/javascript"></script>

    
</body>
</html>
<!--
     FILE ARCHIVED ON 20:35:26 Jul 12, 2018 AND RETRIEVED FROM THE
     INTERNET ARCHIVE ON 17:45:29 Jul 15, 2018.
     JAVASCRIPT APPENDED BY WAYBACK MACHINE, COPYRIGHT INTERNET ARCHIVE.

     ALL OTHER CONTENT MAY ALSO BE PROTECTED BY COPYRIGHT (17 U.S.C.
     SECTION 108(a)(3)).
-->
<!--
playback timings (ms):
  LoadShardBlock: 755.894 (3)
  esindex: 0.008
  captures_list: 792.798
  CDXLines.iter: 17.695 (3)
  PetaboxLoader3.datanode: 82.466 (4)
  exclusion.robots: 0.164
  exclusion.robots.policy: 0.154
  RedisCDXSource: 14.875
  PetaboxLoader3.resolve: 463.004 (2)
  load_resource: 72.78
-->